Little evidence has suggested whether Dap ameliorates DCM by restraining the NADPH oxidases and/or regulating the antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT). Here, FMO5 is linked to familial dilated cardiomyopathy.